BALYO financials
BALYO
969500JJRU82J0JMV072 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Cost of sales | €20.2M | €17.4M |
| Gross profit | €9.0M | €9.3M |
| Operating profit (EBIT) | -€10.7M | -€8.0M |
| Net finance income / (cost) | -€2.6M | -€1.7M |
| Profit before tax | -€13.3M | -€9.7M |
| Income tax expense | €0 | €33.3K |
| Profit for the year | -€13.3M | -€9.8M |
| — attributable to owners | -€13.3M | -€9.8M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | -€13.2M | -€9.7M |
| Per share | ||
| Basic EPS | €-0.08 | €-0.28 |
| Diluted EPS | €-0.08 | €-0.28 |
| Cash flow statement | ||
| Net cash from operating activities | -€15.2M | -€1.7M |
| Net cash from investing activities | -€658.8K | -€120.8K |
| Net cash from financing activities | €29.6M | €2.4M |
| Proceeds from borrowings | €0 | €363.8K |
| Repayments of borrowings | €2.4M | €265.0K |
| Lease liability payments | €871.0K | €584.7K |
| Balance sheet | ||
| Total assets | €56.1M | €36.9M |
| Non-current assets | €5.2M | €5.6M |
| Property, plant & equipment | €838.6K | €895.1K |
| Right-of-use assets | €3.3M | €3.8M |
| Intangible assets & goodwill | €0 | €0 |
| Current assets | €50.9M | €31.4M |
| Inventories | €10.3M | €8.9M |
| Trade & other receivables | €11.2M | €9.8M |
| Cash & equivalents | €22.6M | €8.6M |
| Total equity | €14.7M | -€12.1M |
| Non-current liabilities | €8.9M | €16.5M |
| Long-term borrowings | €4.2M | €11.1M |
| Lease liabilities (non-current) | €2.8M | €3.7M |
| Current liabilities | €32.5M | €32.5M |
| Current portion of long-term borrowings | €2.5M | €2.5M |
| Lease liabilities (current) | €1.2M | €822.9K |
| Derived metrics | ||
| Operating margin | -36.9% | -30.0% |
| Net margin | -45.7% | -36.6% |
| Return on equity | -90.6% | 80.9% |
| Cash conversion ratio | 1.14× | 0.18× |
| Other reported items | ||
| Adjustments For Deferred Tax Expense | €0 | €33.3K |
| Adjustments For Finance Income Cost | -€2.6M | -€293.3K |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | €1.0K | -€1.3M |
| Adjustments For Sharebased Payments | €0 | €109.1K |
| Bank Overdrafts Classified As Cash Equivalents | €22.0K | €22.0K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €22.6M | €8.6M |
| Cash Flows From Used In Operations Before Changes In Working Capital | -€9.3M | -€6.2M |
| Current Payables On Social Security and Taxes Other Than Income Tax | €3.6M | €3.3M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €238.8K | -€115.8K |
| Equity and Liabilities | €56.1M | €36.9M |
| Expense From Sharebased Payment Transactions With Employees | €0 | €109.1K |
| General and Administrative Expense | €8.7M | €7.1M |
| Increase Decrease In Cash and Cash Equivalents | €14.0M | €398.6K |
| Increase Decrease In Working Capital | €5.9M | -€4.5M |
| Intangible Assets Other Than Goodwill | €152.9K | €176.3K |
| Interest Paid Classified As Financing Activities | €605.0K | €139.0K |
| Issued Capital | €13.4M | €2.7M |
| Longterm Deposits | €964.9K | €662.0K |
| Noncurrent Provisions For Employee Benefits | €450.4K | €304.7K |
| Number of Shares Issued | 167.2M | 34.4M |
| Other Adjustments To Reconcile Profit Loss | €28.9K | -€29.6K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €242.2K | €123.2K |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€70.3K | -€44.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€71.7K | -€58.4K |
| Other Finance Income Cost | -€1.9K | -€1.4M |
| Other Operating Income Expense | -€2.2M | -€2.7M |
| Payments To Acquire Or Redeem Entitys Shares | €30.0K | €0 |
| Proceeds From Issuing Shares | €19.6M | €0 |
| Proceeds From Noncurrent Borrowings | €2.0M | €3.0M |
| Research and Development Expense | €5.4M | €4.4M |
| Reserve of Exchange Differences On Translation | -€93.0K | -€335.2K |
| Retained Earnings Excluding Profit Loss For Reporting Period | -€13.7M | -€11.8M |
| Retained Earnings Profit Loss For Reporting Period | -€13.3M | -€9.8M |
| Revenue From Contracts With Customers | €29.1M | €26.7M |
| Sales and Marketing Expense | €3.5M | €3.0M |
| Share Premium | €28.1M | €6.7M |
| Trade and Other Current Payables To Trade Suppliers | €10.6M | €10.1M |
Every line item above is a fact tagged in BALYO's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.